Jimenez aims for savings and marketing rejuvenation
January 28, 2008Sales and Marketing Jimenez, Jiminez, Novartis
The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …
Pfizer sales dip during year of restructuring
January 25, 2008Sales and Marketing generics
Pfizer’s pharmaceutical sales fell slightly last year, hit by patent expiries and difficult market conditions for its leading drug Lipitor. …
Avandia hit by further restrictions
January 25, 2008Sales and Marketing reg, safety
GlaxoSmithKline has strengthened the safety warnings on its diabetes drug Avandia following recommendations from European regulators. The drug was hit …
Avastin launched in UK for kidney cancer
January 25, 2008Sales and Marketing avastin, rcc
Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …
PR firm Chamberlain opens European office
January 25, 2008Medical Communications PR
American PR firm Chamberlain is to expand into Europe with the opening of new operations in London. Chamberlain Healthcare Public …
Athena picks up account for key Bayer Schering product
January 24, 2008Medical Communications
Bayer Schering Pharma has appointed Athena Medical PR to handle the UK PR campaign for its anti-coagulant Xarelto ahead of …
NICE contributes to government’s anti-obesity vision
January 24, 2008Sales and Marketing hc
The rise of obesity in Britain could be halted if exercise were built into individual daily routines, according to new …
Genmab’s MabThera rival enters phase III
January 24, 2008Sales and Marketing
Genmab and GSK's new biotech drug HuMax has entered phase III trials for use in rheumatoid arthritis, the first of …
Pharmafocus: The NHS in Review
January 24, 20082007, NHS, healthcare, year in review
First, the good news. So easy to overlook when the headlines are filled with tales of threats to close A&E …
Latest news from Datamonitor
January 24, 2008Research and Development
Access licenses MuGard to Rhei Pharmaceuticals Access Pharmaceuticals and Rhei Pharmaceuticals have signed a definitive licensing agreement under which Rhei …
Roche invests in Germany and Swiss biotech sites
January 18, 2008Manufacturing and Production, Research and Development
Swiss pharmaceutical company Roche is to invest $390 million (430 million Swiss francs) in three of its European sites to …
Pharma companies raided over alleged generic blocking
January 18, 2008Sales and Marketing
Pharmaceutical companies across Europe have been raided by EU investigators who suspect illegal moves to block the launch of cheaper …
Pharmafocus: A Year in Review
January 17, 2008Research and Development, Sales and Marketing 2007, biotech, pharma, year in review
A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …
US problems hit Novartis
January 17, 2008Sales and Marketing generics
The entry of three generic competitors and the withdrawal of irritable bowel drug Zelnorm wiped billions off Novartis' revenues in …
MPs call for more generic prescribing
January 17, 2008Sales and Marketing
Pharmaceutical marketing and the NHS drugs bill are once again in the spotlight with MPs criticising the industry's influence and …
European research service to track technology adoption by physicians
January 17, 2008Sales and Marketing
US market research company Manhattan Research has launched a new European service to examine trends in physician's use of technology …
GSK’s allergy treatment Avamys approved in Europe
January 17, 2008Sales and Marketing
European regulators have approved GlaxoSmithKline's new once-daily corticosteroid nasal spray for allergic rhinitis. Avamys was granted a licence to treat …
AstraZeneca puts Crestor head-to-head with Lipitor
January 17, 2008Research and Development
AstraZeneca's Crestor will go head-to-head with Pfizer's mega-brand Lipitor in a global trial assessing the two statins in cardiovascular disease. …
Pfizer boosts pipeline with biotech tissue deal
January 16, 2008Research and Development
Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …
Stakeholders clash over European patient information
January 16, 2008Medical Communications
Stakeholders have voiced fresh fears pharma is moving towards advertising prescription medicines to consumers after the European Commission continued in …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
